Antisense oligonucleotide-based targeting of Tau-tubulin kinase 1 prevents hippocampal accumulation of phosphorylated tau in PS19 tauopathy mice
Citation: Acta Neuropathologica Communications 2023 11:166
Ionis Pharmaceuticals is exploiting its expertise in RNA to discover and develop novel human therapeutic drugs for patients. The company is also developing a biosensor to identify infectious organisms.
Page 1 of 2